← Back to all trials
Completed
NCT05598242
Amniotic Membrane Treatment for Hyposecretory Dry Eye
Conditions: Dry Eye Syndromes, Sjogren Syndrome With Keratoconjunctivitis
Sex: Female
Ages: 21 Years – N/A
Phase: PHASE3
Enrollment: 37
Sponsor: Hospital Nacional Profesor Alejandro Posadas
Location: Argentina
Summary
The goal of this randomized, active-controlled, parallel-group trial is to evaluate the clinical efficacy of amniotic membrane extract eye drops (AMEED) in reducing signs and symptoms of hyposecretory dry eyeParticipants will receibed amniotic membrane extract eye drops 6 times daily and was evaluated at baseline day and day 30th.Researchers will compare against autologous serum eye drops effects
Eligibility Criteria
Inclusion Criteria:21 years of age or olderdry eye related symptomsFluorescein Corneal Staining score of 4 or moreLisamina Green Conjunctival score of 4 or morea no-anesthesia Schirmer test value at 5' of 10 mm or lessExclusion Criteria:glaucoma treatmentsurgical procedures within 3 months of the baseline evaluationprecense of punctal plugpatients that were human immunodeficiency virus positive
Source: ClinicalTrials.gov (NCT05598242). StuddyBuddy aggregates publicly available trial information.
